The addition of glucagon in the dual-hormone (insulin and glucagon) system can further reduce hypoglycaemia but limited data exist so far to quantify the improved safety compared with the single-hormone system with announced physical activity. The gene discussed is GCG; the disease is Hypoglycemia.